0001140361-18-041597.txt : 20181030
0001140361-18-041597.hdr.sgml : 20181030
20181030100013
ACCESSION NUMBER: 0001140361-18-041597
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181026
FILED AS OF DATE: 20181030
DATE AS OF CHANGE: 20181030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coelho Mary Theresa
CENTRAL INDEX KEY: 0001720772
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13648
FILM NUMBER: 181145722
MAIL ADDRESS:
STREET 1: 52 SUNRISE PARK ROAD
CITY: NEW HAMPTON
STATE: NY
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BALCHEM CORP
CENTRAL INDEX KEY: 0000009326
STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800]
IRS NUMBER: 132578432
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P O BOX 600
CITY: NEW HAMPTON
STATE: NY
ZIP: 10958
BUSINESS PHONE: 8453265632
MAIL ADDRESS:
STREET 1: P O BOX 600
CITY: NEW HAMPTON
STATE: NY
ZIP: 10958
4
1
form4.xml
FORM 4
X0306
4
2018-10-26
0000009326
BALCHEM CORP
BCPC
0001720772
Coelho Mary Theresa
C/O BALCHEM CORPORATION
52 SUNRISE PARK ROAD
NEW HAMPTON
NY
10958
true
Chief Financial Officer
Common Stock
2018-10-29
4
F
0
1187
96.42
D
2105
D
Employee Stock Option (Right to Buy)
74.57
2018-10-26
4
A
0
1132
0
A
2018-10-26
2028-02-15
Common Stock
1132
3337
D
The Company granted 5,605 restricted shares under the Company's Long-Term Incentive Program. The shares were subject to certain restrictions under the applicable Restricted Stock Grant Agreements. 1,187 of the 3,210 shares that vested October 26, 2018 were withheld to cover withholding taxes due upon vesting.
In connection with a Separation Agreement and General Release (SA&GR) between the Company and the reporting person, 1,050 shares previously reported as beneficially owned in connection with Restricted Stock Grant Agreements were forfeited.
On February 15, 2018, the reporting person was granted an option to purchase 5,030 shares of common stock scheduled to vest in installments of 20%, 40%, and 40% per year over the three-year period. The option reported herein as acquired resulted from the acceleration of vesting of 22.5% of such option in connection with a SA&GR.
/s/ Mary Theresa Coelho, by Attorney in Fact, Mark Stach
2018-10-29